NEW YORK, Jan. 21, 2015 /PRNewswire/ -- Chardan Capital Markets is pleased to announce today the hiring of Keay Nakae Senior Research Analyst – Healthcare. Mr. Nakae has over 15 years of experience as a sell-side research analyst covering healthcare companies, and has previously worked at Ascendiant Capital Markets. He has made numerous media appearances on Bloomberg TV, and has been quoted in publications such as The Wall Street Journal, Time, Business Week, and the Los Angeles Times. Mr. Nakae also has been recognized by Forbes magazine in its annual survey of America's Best Analysts.
"We are delighted to have Mr. Nakae join us and believe his experience, depth of knowledge and strong analytical capabilities will be a valuable addition to our Biotechnology, Healthcare and Pharmaceutical research universe," said Jay Srivatsa Managing Director of Equity Research at Chardan. Mr. Nakae holds an MBA in finance from the Anderson School at UCLA, MS and BS degrees in Electronic Engineering from California Polytechnic State University in San Luis Obispo. He is a CFA charter holder.
About Chardan Capital Markets, LLC
Chardan Capital Markets ("Chardan") provides a full suite of Global Investment Banking services designed for micro, small and mid-cap emerging growth companies. Our full range of services includes capital raising, merger and acquisition advisory, strategic advisory, equity research, institutional trading and market making. Headquartered in New York City, with offices in Palo Alto, Sydney, Beijing and coming in 2015 Tel Aviv. Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, MSRB, SIPC, NASDAQ and the NYSE.
To learn more about Chardan Capital Markets, visit www.chardancm.com
SOURCE Chardan Capital Markets